BOULDER, Colo.--(BUSINESS WIRE)--Cold and Flu Response, LLC (www.ColdAndFluResponse.com), the maker of Formula LP, announced today the results of a recent study conducted at the University of Alberta Medical School to determine the effectiveness of commercial immune boosting products. When cultured lymphocytes were exposed to Formula LP, they responded with a greater growth rate than the control, while the rest of the products did not exhibit significant growth. With respect to fighting potential bacterial and viral infections, lymphocyte proliferation is a good measure of immune response; none of the other products demonstrated this activity. The study concluded that Formula LP significantly out-performs the leading products in the Immune category.
